News archive

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

We are pleased to pre‐announce the transnational call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. The call involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR SRIA.

In preparation for the future OH AMR Partnership, JPIAMR invites the research community to share its view on gaps in the AMR funding landscape and the requirements for potential funding mechanisms with impact.

A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.

The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR.

The JPIAMR has launched a round of consultation on antiparasitic and antiviral resistance. The information will be used for outlining research and innovation priorities in the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance and informing the scope and direction of the candidate One Health AMR partnership. 

The review “Tackling the emerging threat of antifungal resistance to human health” has been published in the April edition of Nature Reviews Microbiology. The review was written by the expert group on antifungals that led the broadening on the JPIAMR Strategic Research and Innovation Agenda in 2021.

The JPIAMR has launched a round of public consultation on the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance in preparation for the One Health AMR partnership.

The JPIAMR Activity Report that was published today summarises the JPIAMR achievements and major events for the year 2021.